CME
Shifting Paradigms for Assessment and Management of Lower-Risk Myelodysplastic Syndromes: Genomics, Risk Stratification, and Novel Therapies
Host: Rami Komrokji, MD
Guest: Michael R. Savona, MD
Guest: Jamile Shammo, MD, FASCP, FACP
Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms associated with cytopenias, suboptimal production of mature erythrocytes, an